Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$162.0K
591.00 shares
What this filing means
MESA NILDA plans to sell 591.00 shares of UNITED THERAPEUTICS CORP valued at approximately $162.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2024ACC: 0001950047-24-005025
591.00
Shares to sell
$162.0K
Approx. market value
266.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
6/29/2020
266.00Total acquired266.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/29/2020 | Restricted Stock Not Applicable | 266.00 | — |
| Total | 266.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
325.00
Market value
$77.3K
3/27/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
266.00
Market value
$84.7K
6/25/2024
Total
Units
591.00
Value
$162.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/27/2024 | 325.00 | $77.3K | — | Completed |
| Planned — Approximate Date | ||||
6/25/2024 | 266.00 | $84.7K | NASDAQ | Planned |
| Total | 591.00 | $162.0K | ||